Tenorio-Laranga J

References (7)

Title : The expression levels of prolyl oligopeptidase responds not only to neuroinflammation but also to systemic inflammation upon liver failure in rat models and cirrhotic patients - Tenorio-Laranga_2015_J.Neuroinflammation_12_183
Author(s) : Tenorio-Laranga J , Montoliu C , Urios A , Hernandez-Rabaza V , Ahabrach H , Garcia-Horsman JA , Felipo V
Ref : J Neuroinflammation , 12 :183 , 2015
Abstract : Tenorio-Laranga_2015_J.Neuroinflammation_12_183
ESTHER : Tenorio-Laranga_2015_J.Neuroinflammation_12_183
PubMedSearch : Tenorio-Laranga_2015_J.Neuroinflammation_12_183
PubMedID: 26420028

Title : Alteration of prolyl oligopeptidase and activated alpha-2-macroglobulin in multiple sclerosis subtypes and in the clinically isolated syndrome - Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
Author(s) : Tenorio-Laranga J , Peltonen I , Keskitalo S , Duran-Torres G , Natarajan R , Mannisto PT , Nurmi A , Vartiainen N , Airas L , Elovaara I , Garcia-Horsman JA
Ref : Biochemical Pharmacology , 85 :1783 , 2013
Abstract : Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
ESTHER : Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
PubMedSearch : Tenorio-Laranga_2013_Biochem.Pharmacol_85_1783
PubMedID: 23643808

Title : Prolyl oligopeptidase: a rising star on the stage of neuroinflammation research - Penttinen_2011_CNS.Neurol.Disord.Drug.Targets_10_340
Author(s) : Penttinen A , Tenorio-Laranga J , Siikanen A , Morawski M , Rossner S , Garcia-Horsman JA
Ref : CNS Neurol Disord Drug Targets , 10 :340 , 2011
Abstract : Penttinen_2011_CNS.Neurol.Disord.Drug.Targets_10_340
ESTHER : Penttinen_2011_CNS.Neurol.Disord.Drug.Targets_10_340
PubMedSearch : Penttinen_2011_CNS.Neurol.Disord.Drug.Targets_10_340
PubMedID: 21222623

Title : Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner - Myohanen_2011_Br.J.Pharmacol_163_1666
Author(s) : Myohanen TT , Tenorio-Laranga J , Jokinen B , Vazquez-Sanchez R , Moreno-Baylach MJ , Garcia-Horsman JA , Mannisto PT
Ref : British Journal of Pharmacology , 163 :1666 , 2011
Abstract : Myohanen_2011_Br.J.Pharmacol_163_1666
ESTHER : Myohanen_2011_Br.J.Pharmacol_163_1666
PubMedSearch : Myohanen_2011_Br.J.Pharmacol_163_1666
PubMedID: 21133893

Title : Hunting for peptide substrates of prolyl oligopeptidase: classical versus non-classical bioactive peptides - Tenorio-Laranga_2011_CNS.Neurol.Disord.Drug.Targets_10_319
Author(s) : Tenorio-Laranga J , Mannisto PT , Garcia-Horsman JA
Ref : CNS Neurol Disord Drug Targets , 10 :319 , 2011
Abstract : Tenorio-Laranga_2011_CNS.Neurol.Disord.Drug.Targets_10_319
ESTHER : Tenorio-Laranga_2011_CNS.Neurol.Disord.Drug.Targets_10_319
PubMedSearch : Tenorio-Laranga_2011_CNS.Neurol.Disord.Drug.Targets_10_319
PubMedID: 21222622

Title : Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis - Tenorio-Laranga_2010_J.Neuroinflammation_7_23
Author(s) : Tenorio-Laranga J , Coret-Ferrer F , Casanova-Estruch B , Burgal M , Garcia-Horsman JA
Ref : J Neuroinflammation , 7 :23 , 2010
Abstract : Tenorio-Laranga_2010_J.Neuroinflammation_7_23
ESTHER : Tenorio-Laranga_2010_J.Neuroinflammation_7_23
PubMedSearch : Tenorio-Laranga_2010_J.Neuroinflammation_7_23
PubMedID: 20370893

Title : Characterization of membrane-bound prolyl endopeptidase from brain - Tenorio-Laranga_2008_FEBS.J_275_4415
Author(s) : Tenorio-Laranga J , Venalainen JI , Mannisto PT , Garcia-Horsman JA
Ref : Febs J , 275 :4415 , 2008
Abstract : Tenorio-Laranga_2008_FEBS.J_275_4415
ESTHER : Tenorio-Laranga_2008_FEBS.J_275_4415
PubMedSearch : Tenorio-Laranga_2008_FEBS.J_275_4415
PubMedID: 18657187